LEO US Holding, Inc. entered into a definitive agreement to acquire Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, for a total transaction value of up to $36 million. The initial upfront consideration of $14 million and up to an additional $22.0 million in contingent value rights (CVRs) is payable upon achievement of certain milestones with respect TMB-001 for the t...